J Sprouse
Overview
Explore the profile of J Sprouse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kessler E, Sprouse J, Harrington M
Neuroscience
. 2008 Jun;
154(4):1187-94.
PMID: 18538936
Health problems can arise from de-synchrony between the external environment and the endogenous circadian rhythm, yet the circadian system is not able to quickly adjust to large, abrupt changes in...
2.
SMATHERS S, Wallner K, Sprouse J, True L
Int J Radiat Oncol Biol Phys
. 2001 Aug;
50(5):1207-11.
PMID: 11483330
Purpose: The long-standing confusion regarding the clinical relevance of postimplant biopsies is complicated by the common occurrence of temporary PSA rises between 1 and 2 years after brachytherapy. We report...
3.
Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H
Synapse
. 2001 May;
41(1):49-57.
PMID: 11354013
Systemic doses of fluoxetine slow dorsal raphe cell firing by blocking the reuptake carrier located in the cell body region with the surplus 5-HT thus generated activating inhibitory autoreceptors. The...
4.
Sprouse J, Braselton J, Reynolds L
Biol Psychiatry
. 2000 Jun;
47(12):1050-5.
PMID: 10862804
Background: The ability of pindolol to block 5-HT(1A) autoreceptors on serotonin-containing neurons in the raphe nuclei is thought to underlie the clinical reports of enhanced efficacy and rate of improvement...
5.
Sprouse J, Braselton J, Reynolds L
Ann N Y Acad Sci
. 1999 Feb;
861:274-5.
PMID: 9928287
No abstract available.
6.
Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H
Ann N Y Acad Sci
. 1999 Feb;
861:272-3.
PMID: 9928286
No abstract available.
7.
Sprouse J, Reynolds L, Rollema H
Neuropharmacology
. 1997 Apr;
36(4-5):559-67.
PMID: 9225281
GR127935 is a selective antagonist of release-modulating 5-HT1B/1D autoreceptors on serotonergic terminals and, as such, would be expected to produce increases in extracellular 5-HT. The changes in 5-HT observed are...
8.
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
Schulz D, Mansbach R, Sprouse J, Braselton J, Collins J, Corman M, et al.
Proc Natl Acad Sci U S A
. 1996 Sep;
93(19):10477-82.
PMID: 8816826
Here we describe the properties of CP-154,526, a potent and selective nonpeptide antagonist of corticotropin (ACTH) releasing factor (CRF) receptors. CP-154,526 binds with high affinity to CRF receptors (Ki <...
9.
Sprouse J, Clarke T, Reynolds L, Heym J, Rollema H
Neuropsychopharmacology
. 1996 Apr;
14(4):225-31.
PMID: 8924190
N-demethylation of the selective serotonin reuptake inhibitor sertraline to desmethylsertraline yields a compound with 10- to 20-fold less potency at blocking serotonin (5-HT) reuptake as measured in vitro. In the...
10.
Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tlsty T
Cell
. 1992 Sep;
70(6):923-35.
PMID: 1356076
Gene amplification occurs at high frequency in transformed cells (10(-3)-10(-5)), but is undetectable in normal diploid fibroblasts (less than 10(-9)). This study examines whether alterations of one or both p53...